Congratulations to one of our portfolio companies – medical device innovator ABK Biomedical – on its recent Series B round.
The C$40-million financing is the largest venture capital round ever in Atlantic Canada. Investors included F-Prime Capital and Varian Medical Systems. The money will be used to further develop ABK’s liver tumour radiation technology. The company is developing microspheres (tiny glass beads) that will be injected into tumours to block blood flow. Innovacorp is proud to be a seed investor in ABK, and we often brag that the team spent its earliest years at our life sciences incubation facility in Halifax. Founders Dr. Bob Abraham, Dr. Daniel Boyd and Dr. Sharon Kehoe all maintain active roles in the company.
Way to go, ABK! We can’t wait for your venture’s next milestone!
May 2019, Halifax, Nova Scotia